STAMFORD, Conn.--(BUSINESS WIRE)--Aug 28, 2018--Purdue Pharma L.P. and research collaborators will present the results of four studies at the 12 th Annual PAINWeek® Conference, September 4-8, 2018, Las Vegas, Nev.

Poster presentations include:

The posters will be available for viewing after 3:30 p.m. PDT on Wednesday, September 5, 2018. Authors will be available to discuss their posters during the PAINWeek® Poster Session and Reception on Thursday, September 6, 2018 from 6:30 – 8:30 p.m. PDT.

About Purdue Pharma L.P.

Purdue Pharma L.P. develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and we are currently led by a physician. Beyond our efforts to provide quality medications, Purdue is committed to supporting national, regional and local collaborations to drive innovations in patient care. Privately held, Purdue is pursuing a pipeline of new medications and technologies through internal research & development and strategic industry partnerships. For more information, please visit  www.purduepharma.com.

1 Geisinger, Danville, PA 2 Purdue Pharma L.P., Stamford, CT 3 University of Oklahoma College of Pharmacy, Oklahoma City, OK 4 Pharmacy Management Consultants, Oklahoma City, OK

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005181/en/

CONTACT: Media:

Purdue Pharma L.P.

Danielle Lewis, +1-203-588-7653

danielle.lewis@pharma.com

KEYWORD: UNITED STATES NORTH AMERICA CONNECTICUT NEVADA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL COMMUNICATIONS PUBLIC RELATIONS/INVESTOR RELATIONS GENERAL HEALTH

SOURCE: Purdue Pharma L.P.

Copyright Business Wire 2018.

PUB: 08/28/2018 08:30 AM/DISC: 08/28/2018 08:30 AM

http://www.businesswire.com/news/home/20180828005181/en